Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The impact of walking speed on the effects of functional electrical stimulation for foot drop in people with multiple sclerosis.
High and dysregulated secretion of epidermal growth factor from immune cells of patients with relapsing-remitting multiple sclerosis.
Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
Immunology: A tolerant approach.
Association Between CD24-P226-C/T Polymorphism and Multiple Sclerosis: A Meta-Analysis.
Chronic inflammatory demyelinating polyradiculoneuropathy: revisiting the role of intravenous immmunoglobulins.
Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models.
The validity and reliability of the neurogenic bladder symptom score (NBSS).
Merck KGaA to try again to get approval for MS pill cladribine
Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis.
AP-1 Mediated Transcriptional Repression of Matrix Metalloproteinase-9 by Recruitment of Histone Deacetylase 1 in Response to Interferon β.
Metabolic and safety issues for multiple sclerosis pharmacotherapy - opportunities for personalised medicine.
Oral BG-12 in multiple sclerosis.
Longitudinal Penalized Functional Regression for Cognitive Outcomes on Neuronal Tract Measurements.
Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?
Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided).
Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study.
Multiparametric flow cytometric analysis of whole blood reveals changes in minor lymphocyte subpopulations of multiple sclerosis patients.
Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety.
Fingolimod-Associated Peripheral Vascular Adverse Effects.
Pathology and disease mechanisms in different stages of multiple sclerosis.
Lack of response to rituximab therapy in patients with neuromyelitis optica: Response to Kim and Kim.
Incidence and prevalence of multiple sclerosis in southeastern Iran.
Could Intrathymic Injection of Myelin Basic Protein Suppress Inflammatory Response After Co-culture of T Lymphocytes and BV-2 Microglia Cells?
The Ex Vivo Production of IL-6 and IL-21 by CD4(+) T Cells is Directly Associated with Neurological Disability in Neuromyelitis Optica Patients.

Pages